State of New Jersey Common Pension Fund D grew its position in Integer Holdings Co. (NYSE:ITGR – Free Report) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,722 shares of the medical equipment provider’s stock after purchasing an additional 140 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Integer were worth $2,083,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Loomis Sayles & Co. L P raised its holdings in Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after purchasing an additional 15,446 shares during the period. Jane Street Group LLC raised its holdings in shares of Integer by 23.3% during the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock worth $19,682,000 after acquiring an additional 28,572 shares during the period. Verition Fund Management LLC raised its holdings in shares of Integer by 17.4% during the third quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after acquiring an additional 515 shares during the period. Versant Capital Management Inc raised its holdings in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after acquiring an additional 183 shares during the period. Finally, KBC Group NV raised its holdings in shares of Integer by 83.3% during the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock worth $212,000 after acquiring an additional 726 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages recently commented on ITGR. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Friday. KeyCorp raised their price objective on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price objective on shares of Integer in a report on Tuesday, December 3rd. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, Citigroup lifted their price target on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $147.67.
Integer Stock Performance
Shares of ITGR opened at $129.96 on Friday. The firm has a 50-day moving average of $137.74 and a 200-day moving average of $132.44. Integer Holdings Co. has a one year low of $98.63 and a one year high of $146.36. The company has a market cap of $4.36 billion, a PE ratio of 38.68, a price-to-earnings-growth ratio of 1.72 and a beta of 1.13. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09.
Integer (NYSE:ITGR – Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. As a group, equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.
Integer Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
- Five stocks we like better than Integer
- Dividend Payout Ratio Calculator
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What is the Hang Seng index?
- DuPont’s Electronics Spinoff: The Start of Something Big
- Best Stocks Under $5.00
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.